Literature DB >> 11587282

Is there a future for clinical ethics services in Australia?

I H Kerridge1, J Savulescu, P A Komesaroff.   

Abstract

Clinical ethics refers to the consideration of ethical issues arising directly in the context of patient care. Health professionals are generally adept at effectively and sensitively managing ethical issues in clinical care. However, in some settings, multidisciplinary clinical ethics services may enhance clinical practice by assisting clinicians, patients and others to identify, understand and manage ethical issues. Clinical ethics services may be particularly valuable for situations in which moral perspectives diverge or communication has deteriorated. Such services may facilitate discussion and help the parties find mutually satisfactory solutions. Clinical ethics services may take various forms, including clinical ethics committees, ethics consultants, patient advocates or other mechanisms for responding to complaints and grievances. There is considerable disagreement about key aspects of clinical ethics services, including who should conduct them, how they should be run and what role they should play in decision-making.

Entities:  

Keywords:  Professional Patient Relationship

Mesh:

Year:  2001        PMID: 11587282     DOI: 10.5694/j.1326-5377.2001.tb143098.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

Review 1.  Hospital/clinical ethics committees' notion: an overview.

Authors:  Fatemeh Hajibabaee; Soodabeh Joolaee; Mohammad Ali Cheraghi; Pooneh Salari; Patricia Rodney
Journal:  J Med Ethics Hist Med       Date:  2016-12-18

2.  Evaluating assessment tools of the quality of clinical ethics consultations: a systematic scoping review from 1992 to 2019.

Authors:  Nicholas Yue Shuen Yoon; Yun Ting Ong; Hong Wei Yap; Kuang Teck Tay; Elijah Gin Lim; Clarissa Wei Shuen Cheong; Wei Qiang Lim; Annelissa Mien Chew Chin; Ying Pin Toh; Min Chiam; Stephen Mason; Lalit Kumar Radha Krishna
Journal:  BMC Med Ethics       Date:  2020-07-01       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.